<DOC>
	<DOC>NCT00856414</DOC>
	<brief_summary>This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)</brief_summary>
	<brief_title>Patient Satisfaction With Treatment of BOTOXÂ® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Female subjects of any race, 3555 years of age Moderate to severe glabellar wrinkles (lines between the eyebrows) Previous botulinum toxin therapy Subjects who are pregnant, breastfeeding, or who are of childbearing potential and not practicing a reliable method of birth control Subjects planning a facial cosmetic procedure or visible scars Previous cosmetic surgery to the upper face Medical condition that may increase their risk of exposure to botulinum toxin including diagnosed Myasthenia Gravis, EatonLambert Syndrome, Amyotrophic Lateral Sclerosis, or any other disease that might interfere with neuromuscular function History of facial nerve palsy Allergy or sensitivity to any component of the study medication</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>